Company Name: Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. is a cancer-focused clinical stage biopharmaceutical company. The company is engaged in the development of small molecule drug candidates utilizing its proprietary kinase switch control inhibitor platform.

Ticker Symbol: DCPH (NASDAQ)

Company Website: https://www.deciphera.com

Social Media:

Deciphera Pharmaceuticals Linkedin

Headquarters: Waltham, MA